Current Practice and Barriers to an Early Antimicrobial Conversion from Intravenous to Oral among Hospitalized Patients at Jimma University Specialized Hospital: Prospective Observational Study

Table 3

Intravenous to oral antimicrobial therapy conversion outcomes at Jimma University Specialized Hospital, South West Ethiopia, February–September, 2014.

Variable	Implementation
Duration of IV therapy
all patients
mean± SD	7.66 ± 3.25 (n=142)
median; range	7; 0 – 15
converted patients
mean± SD	3.30 ± 2.26 (n=20)
non-converted patients
mean± SD	8.64 ± 2.70 (n=44)
Time to clinical stability (days )
all patients
mean± SD	6.04± 3.25 (n=136)
median; range	5;0 – 16
converted patients
mean± SD	3.40± 2.37 (n=20)
non-converted patients
mean± SD	8.69± 3.73(n=44)
Observation period after conversion (days )
mean± SD	5.18± 4.60 (n=28)
median; range	4.5;0 – 15
Duration of IV therapy after clinical stability for non-converted patients (days)
mean ±SD	3.23± 2.09 (n=44)
median; range	3; 0 – 8
Number of IV antimicrobial prescriptions for which duration was specified (n=total number of prescriptions)	7(n=174)
Length of hospital stay (days)
all patients
mean± SD	13.42 ± 7.89(n=142)
median; range	11; 1 – 44
converted patients
mean± SD	9.0 ± 5.23 (n=20)
non-converted patients
mean± SD	13.45 ± 5.48 (n=44)
Total antibiotic acquisition costs (birr)	24495.04
Cost saving analysis
Total amount saved
Converted groups	3074.84 (n=20)
Non-converted groups	4080.06 (n= 44)